Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
“Patients hospitalized for HFrEF in US clinical practice are at very high risk of poor clinical outcomes, even when prescribed quadruple medical therapy.” — Dr. Stephen J. Greene, Duke Clinical Research Institute
Cardiology February 23rd 2026
Medical News Today (MNT)
Even if menopause does lead to some gray matter loss, it won’t automatically lead to future cognitive decline or dementia.
Geriatrics February 11th 2026
Cath Lab Digest
Given that the patient lived 80 years with this congenital condition without right atrial or right ventricular enlargement or significant pulmonary hypertension, the decision was made to manage medically.
Cardiology February 10th 2026
MDLinx
“The key word is association. This study does not establish causality. For absolute, catastrophic harm to an appropriately selected, monitored pain patient, the risk is small.” – Sean Mackey, MD, PhD, Chief of the Division of Stanford Pain Medicine
Clinical Pharmacology February 6th 2026
Annals of Internal Medicine
Despite the scale of prostate-specific antigen (PSA) testing for prostate cancer screening, prediction models do not predict time-to-event end points or adjust for patient life expectancy.
Family Medicine/General Practice February 6th 2026
Cleveland Clinic Journal of Medicine (CCJM)
Studies have shown a mean effect size with CBTI of 0.96 compared with 0.87 for pharmacotherapy, suggesting similar efficacy in short term but CBTI seems to have longer-lasting effects.